Search Results - "Schelch, K."

Suppression of activin A signals inhibits growth of malignant pleural mesothelioma cells by Hoda, M A, Münzker, J, Ghanim, B, Schelch, K, Klikovits, T, Laszlo, V, Sahin, E, Bedeir, A, Lackner, A, Dome, B, Setinek, U, Filipits, M, Eisenbauer, M, Kenessey, I, Török, S, Garay, T, Hegedus, B, Catania, A, Taghavi, S, Klepetko, W, Berger, W, Grusch, M

“…Background: Activins control the growth of several tumour types including thoracic malignancies. In the present study, we investigated their expression and…”
Get full text

Clinical and prognostic implications of CD47 and PD-L1 expression in surgically resected small-cell lung cancer by Lang, C., Lantos, A., Megyesfalvi, Z., Egger, F., Hoda, M.A., Mosleh, B., Klikovits, T., Oberndorfer, F., Timelthaler, G., Ferencz, B., Fillinger, J., Schwendenwein, A., Querner, A.S., Boettiger, K., Renyi-Vamos, F., Hoetzenecker, K., Laszlo, V., Schelch, K., Dome, B.

“…Pharmacological inhibition of the immune-checkpoint molecule CD47 has shown promising results in preclinical small-cell lung cancer (SCLC) models, whereas…”
Get full text

Proteomic analysis of brain metastatic lung adenocarcinoma reveals intertumoral heterogeneity and specific alterations associated with the timing of brain metastases by Woldmar, N., Schwendenwein, A., Kuras, M., Szeitz, B., Boettiger, K., Tisza, A., László, V., Reiniger, L., Bagó, A.G., Szállási, Z., Moldvay, J., Szász, A.M., Malm, J., Horvatovich, P., Pizzatti, L., Domont, G.B., Rényi-Vámos, F., Hoetzenecker, K., Hoda, M.A., Marko-Varga, G., Schelch, K., Megyesfalvi, Z., Rezeli, M., Döme, B.

“…Brain metastases are associated with considerable negative effects on patients’ outcome in lung adenocarcinoma (LADC). Here, we investigated the proteomic…”
Get full text

838 The FGF Axis in Melanoma – FGF5 as Novel Player and Combination Strategies for Effective Targeting by Grusch, M, Ghassemi, S, Vejdovszky, K, Schelch, K, Spiegl-Kreinecker, S, Heffeter, P, Pirker, C, Berger, W

Get full text